The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Earning passive income online is more accessible than ever. Discover effective strategies to start your online income journey.
15,272 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Global equities outside the US have surged as growth improves and the dollar weakens. This article highlights three E...
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Investors are looking at SMH with fresh eyes as AI infrastructure expands. This article explains why a bold predictio...
Berkshire Hathaway buying back its own stock marks a notable shift in how the company uses cash. Even a modest repurc...
Gallup's newest Life Evaluation Index shows more american workers struggling than thriving for the first time in the ...
A headline about Palantir and a high-stakes defense AI plan could reshape risk and opportunity. This guide breaks dow...
Coinbase again declines to back the revamped Digital Asset Market Clarity Act, citing significant concerns as lawmake...
Broadcom stands at a pivotal crossroads as AI spending shifts from pilots to production. This article lays out the ke...
Deficits are mounting as the Treasury plots heavy borrowing for the current and next fiscal years. Officials project ...
MP Materials is shaping the materials landscape with its Mountain Pass operation. This guide breaks down what to wat...
Lucid Group has faced a tough year, with its stock down dramatically. This article breaks down the reasons behind the...